Biopharma CreditBOPCF
13F holders, Q4 2025 (December 31)1holders
0new positions
0sold out
$0.92avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Biopharma Credit PLC (BOPCF) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holder was Aubrey Capital Management Ltd ($2.7M).
- Company
- Biopharma Credit PLC
- CUSIP
- G12808104
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 101,000 shares sold, net −101,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Aubrey Capital Management Ltd | 1.07% | Reduce -3.3% | 2,950,990 | $2.7M |
"% of holder's portfolio" is BOPCF's weight in each manager's 13F, not the share of Biopharma Credit PLC the manager owns.